Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

1.

Clostridium perfringens Endophthalmitis After Penetrating Keratoplasty With Contaminated Corneal Allografts: A Case Series.

Hou JH, Tannan A, Rubenstein JB, Lopez OI, McCoy K, Epstein RJ, Grostern RJ, Sugar J.

Cornea. 2014 Nov 12. [Epub ahead of print]

PMID:
25393093
[PubMed - as supplied by publisher]
2.
3.

October consultation #4.

Epstein RJ.

J Cataract Refract Surg. 2014 Oct;40(10):1749-50; discussion 1751. doi: 10.1016/j.jcrs.2014.08.007. No abstract available.

PMID:
25263050
[PubMed - in process]
4.

Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis.

Brungs D, Chen J, Masson P, Epstein RJ.

Prostate Cancer Prostatic Dis. 2014 Jun;17(2):105-11. doi: 10.1038/pcan.2014.10. Epub 2014 Apr 1.

PMID:
24686773
[PubMed - in process]
5.

April consultation #2.

Epstein RJ, Grostern R.

J Cataract Refract Surg. 2014 Apr;40(4):684-5; discussion 687. doi: 10.1016/j.jcrs.2014.02.018. No abstract available.

PMID:
24680524
[PubMed - indexed for MEDLINE]
6.

Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAF (V600E)-mutant metastatic colorectal carcinoma.

Connolly K, Brungs D, Szeto E, Epstein RJ.

Curr Oncol. 2014 Feb;21(1):e151-4. doi: 10.3747/co.21.1661.

PMID:
24523613
[PubMed]
Free PMC Article
7.

Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis.

Chiu J, Tang V, Leung R, Wong H, Chu KW, Poon J, Epstein RJ, Yau T.

Asian Pac J Cancer Prev. 2013;14(11):6585-90.

PMID:
24377572
[PubMed - in process]
Free Article
8.

The unpluggable in pursuit of the undruggable: tackling the dark matter of the cancer therapeutics universe.

Epstein RJ.

Front Oncol. 2013 Dec 12;3:304. doi: 10.3389/fonc.2013.00304. Review.

PMID:
24377088
[PubMed]
Free PMC Article
9.

October consultation #5.

Epstein RJ, Epstein RH, Dennis RF, Majmudar PA.

J Cataract Refract Surg. 2013 Oct;39(10):1621-2. doi: 10.1016/j.jcrs.2013.07.030. No abstract available.

PMID:
24075169
[PubMed - indexed for MEDLINE]
10.

Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.

Connolly K, Manders P, Earls P, Epstein RJ.

Cancer Treat Rev. 2014 Mar;40(2):205-14. doi: 10.1016/j.ctrv.2013.08.005. Epub 2013 Aug 22. Review.

PMID:
24051018
[PubMed - indexed for MEDLINE]
11.

Has discovery-based cancer research been a bust?

Epstein RJ.

Clin Transl Oncol. 2013 Nov;15(11):865-70. doi: 10.1007/s12094-013-1071-8. Epub 2013 Sep 4.

PMID:
24002944
[PubMed - indexed for MEDLINE]
12.

Conserved nonsense-prone CpG sites in apoptosis-regulatory genes: conditional stop signs on the road to cell death.

Zhao Y, Epstein RJ.

Evol Bioinform Online. 2013 Jul 14;9:275-83. doi: 10.4137/EBO.S11759. Print 2013.

PMID:
23908585
[PubMed]
Free PMC Article
13.

Death in The New York Times: the price of fame is a faster flame.

Epstein CR, Epstein RJ.

QJM. 2013 Jun;106(6):517-21. doi: 10.1093/qjmed/hct077. Epub 2013 Apr 17.

PMID:
23596265
[PubMed - indexed for MEDLINE]
Free Article
14.

Modernising the regulation of medical migration: moving from national monopolies to international markets.

Epstein RJ, Epstein SD.

BMC Med Ethics. 2012 Oct 5;13:26. doi: 10.1186/1472-6939-13-26.

PMID:
23039098
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Impact of income and education on drug purchasing decisions in Hong Kong Chinese cancer patients: a pilot study.

Chan WM, Mak J, Epstein RJ.

Asian Pac J Cancer Prev. 2011;12(8):2093-6.

PMID:
22292657
[PubMed - indexed for MEDLINE]
Free Article
16.

A new system, the LipiFlow, for the treatment of meibomian gland dysfunction.

Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, Holland EJ, Lemp MA, McDonald JE 2nd, Silbert DI, Blackie CA, Stevens CA, Bedi R.

Cornea. 2012 Apr;31(4):396-404. doi: 10.1097/ICO.0b013e318239aaea.

PMID:
22222996
[PubMed - indexed for MEDLINE]
17.

Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.

Wong H, Lau S, Leung R, Chiu J, Cheung P, Wong TT, Liang R, Epstein RJ, Yau T.

Med Oncol. 2012 Sep;29(3):1536-42. doi: 10.1007/s12032-011-0082-y. Epub 2011 Oct 8.

PMID:
21983862
[PubMed - indexed for MEDLINE]
18.

Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy.

Campone M, Bondarenko I, Brincat S, Hotko Y, Munster PN, Chmielowska E, Fumoleau P, Ward R, Bardy-Bouxin N, Leip E, Turnbull K, Zacharchuk C, Epstein RJ.

Ann Oncol. 2012 Mar;23(3):610-7. doi: 10.1093/annonc/mdr261. Epub 2011 Jun 23.

PMID:
21700731
[PubMed - indexed for MEDLINE]
Free Article
19.

UVA-light and riboflavin-mediated corneal collagen cross-linking.

Letko E, Majmudar PA, Forstot SL, Epstein RJ, Rubinfeld RS.

Int Ophthalmol Clin. 2011 Spring;51(2):63-76. doi: 10.1097/IIO.0b013e31820f21e7. No abstract available.

PMID:
21383580
[PubMed - indexed for MEDLINE]
20.

Unexpected functional similarities between gatekeeper tumour suppressor genes and proto-oncogenes revealed by systems biology.

Zhao Y, Epstein RJ.

J Hum Genet. 2011 May;56(5):369-76. doi: 10.1038/jhg.2011.21. Epub 2011 Mar 3.

PMID:
21368766
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk